Allison JP - Search Results

1

The TRAMP mouse as a model for prostate cancer.

Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED. Hurwitz AA, et al. Among authors: allison jp. Curr Protoc Immunol. 2001 Nov;Chapter 20:20.5.1-20.5.23. doi: 10.1002/0471142735.im2005s45. Curr Protoc Immunol. 2001. PMID: 18432778

2

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

Allison JP, Hurwitz AA, Leach DR. Allison JP, et al. Curr Opin Immunol. 1995 Oct;7(5):682-6. doi: 10.1016/0952-7915(95)80077-8. Curr Opin Immunol. 1995. PMID: 8573312 Review.

3

Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.

Hurwitz AA, Sullivan TJ, Krummel MF, Sobel RA, Allison JP. Hurwitz AA, et al. Among authors: allison jp. J Neuroimmunol. 1997 Mar;73(1-2):57-62. doi: 10.1016/s0165-5728(96)00168-3. J Neuroimmunol. 1997. PMID: 9058759

4

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Kwon ED, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM, Burg MB, Allison JP. Kwon ED, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8099-103. doi: 10.1073/pnas.94.15.8099. Proc Natl Acad Sci U S A. 1997. PMID: 9223321 Free PMC article.

5

Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma.

Hurwitz AA, Townsend SE, Yu TF, Wallin JA, Allison JP. Hurwitz AA, et al. Among authors: allison jp. Int J Cancer. 1998 Jul 3;77(1):107-13. doi: 10.1002/(sici)1097-0215(19980703)77:1<107::aid-ijc17>3.0.co;2-b. Int J Cancer. 1998. PMID: 9639401 Free article.

6

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Hurwitz AA, Yu TF, Leach DR, Allison JP. Hurwitz AA, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10067-71. doi: 10.1073/pnas.95.17.10067. Proc Natl Acad Sci U S A. 1998. PMID: 9707601 Free PMC article.

7

A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance?

Allison JP, Chambers C, Hurwitz A, Sullivan T, Boitel B, Fournier S, Brunner M, Krummel M. Allison JP, et al. Novartis Found Symp. 1998;215:92-8; discussion 98-102, 186-90. doi: 10.1002/9780470515525.ch7. Novartis Found Symp. 1998. PMID: 9760573 Review.

8

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.

van Elsas A, Hurwitz AA, Allison JP. van Elsas A, et al. Among authors: allison jp. J Exp Med. 1999 Aug 2;190(3):355-66. doi: 10.1084/jem.190.3.355. J Exp Med. 1999. PMID: 10430624 Free PMC article.

9

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

Kwon ED, Foster BA, Hurwitz AA, Madias C, Allison JP, Greenberg NM, Burg MB. Kwon ED, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15074-9. doi: 10.1073/pnas.96.26.15074. Proc Natl Acad Sci U S A. 1999. PMID: 10611340 Free PMC article.

10

Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

Hurwitz AA, Foster BA, Kwon ED, Truong T, Choi EM, Greenberg NM, Burg MB, Allison JP. Hurwitz AA, et al. Among authors: allison jp. Cancer Res. 2000 May 1;60(9):2444-8. Cancer Res. 2000. PMID: 10811122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page